Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle-invasive Urothelial Cancer of the Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04658862
What this trial is testing

TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 518
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07639983
What this trial is testing

Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Urinary Bladder Cancer
Sheng Tai 44
Not applicableLooking for participantsNCT07234968
What this trial is testing

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more
Thomas Jefferson University 70
Testing effectiveness (Phase 2)Study completedNCT05226117
What this trial is testing

Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma
IRCCS San Raffaele 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07142200
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
RenJi Hospital 45
Not applicableLooking for participantsNCT06335667
What this trial is testing

MpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

Who this might be right for
Urothelial Bladder CancerMuscle-Invasive Bladder Cancer
University of California, Irvine 30
Not applicableStudy completedNCT05742867
What this trial is testing

Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Bristol-Myers Squibb 115
Large-scale testing (Phase 3)Looking for participantsNCT07566156
What this trial is testing

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Who this might be right for
Urothelial CancerUrinary Bladder Neoplasms
Astellas Pharma Global Development, Inc. 390
Large-scale testing (Phase 3)Looking for participantsNCT06537154
What this trial is testing

NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Peter Black 688
Not applicableLooking for participantsNCT07225205
What this trial is testing

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Who this might be right for
Bladder CancerMuscle Invasive Bladder Cancer (MIBC)Muscle Invasive Bladder Cancer Urothelial Carcinoma+1 more
Johns Hopkins University 130
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Not applicableStudy completedNCT03433924
What this trial is testing

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

Who this might be right for
Urinary Bladder Cancer
AstraZeneca 248
Early research (Phase 1)Ended earlyNCT06448364
What this trial is testing

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+2 more
Pfizer 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04164082
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Flat Urothelial Carcinoma In SituNon-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8+2 more
National Cancer Institute (NCI) 161
Not applicableUnknownNCT02992990
What this trial is testing

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

Who this might be right for
Bladder Cancer
Baylor College of Medicine 30
Not applicableLooking for participantsNCT07673016
What this trial is testing

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Hematuria+1 more
Convergent Genomics, Inc. 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT06503614
What this trial is testing

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma
John Sfakianos 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386746
What this trial is testing

Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderBladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)Looking for participantsNCT06770582
What this trial is testing

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Who this might be right for
Non-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v8
National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Next Page